Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1M-M-RVAXPRO1件: Measles virus vaccine live attenuated---1件: 107
2M071754----1件: 145
3M2591 25 mg QD----1件: 46
4M281----5件: 11, 46, 49, 53, 61
5M281 Injection----1件: 11
6M2951----3件: 13, 46, 49
7M2951 (Other Name: Evobrutinib)1件: Evobrutinib1件: D12467 1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 49
8M2951 50 mg BID----1件: 46
9M2951 75 mg QD----1件: 46
10M5049----1件: 49
11M5049 high dose----2件: 49, 50
12M5049 low dose----1件: 49
13M5049 medium dose----1件: 49
14M923----1件: 46
15MA09-hRPE----1件: 301
16MABCAMPATH1件: Alemtuzumab1件: D02802 1件: CD52 💬-2件: 13, 60
17MABCAMPATH 10 mg/ml concentrado para solución para perfusión1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
18MabCampath ®1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
19MabCampath-1h1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
20MabCampath®1件: Alemtuzumab1件: D02802 1件: CD52 💬-1件: 13
21MabionCD20----1件: 46
22MabionCD20 (candidate biosimilar to rituximab)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
23MABp1 (Bermekimab)1件: Bermekimab1件: D11253 1件: IL1A 💬21件: AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬1件: 51
24MabThera1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
25MabThera (Rituximab)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬4件: 13, 46, 49, 53
26MABTHERA - 1 FIALA 500 MG 50 ML1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 14, 53
27MABTHERA - 2 FIALE 100 MG 10 ML1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 19, 65
28MabThera 100 mg concentrate for solution for infusion1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 222
29MabThera 100mg1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
30MabThera 5001件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 271
31MabThera 500 mg1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
32MabThera 500 mg (10 mg/ml) concentrate for solution for infusion1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
33MabThera 500 mg (10mg/ml)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
34MABTHERA 500 mg concentrado para solución para perfusión1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
35MabThera 500 mg concentrate for solution for infusion1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 222
36MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
37MabThera 500mg1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
38Mabthera Infusion1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 83
39MabThera infusions1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
40Mabthera or biosimilar Rituximab1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 61
41Mabthera or biosimilar rituximab product1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
42MABTHERA*EV 1FL 50ML 500MG1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 46, 222
43MabThera/Rituxan1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
44Mabthera®1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬6件: 13, 35, 43, 44, 46, 93
45MabThera® (rituximab)1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
46MabThera® 100MG1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 43
47MabThera® 500MG1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 43
48MabThera®, 100 mg Concentrado para solución para perfusión1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
49MabThera®, 100 mg concentrate for solution for infusion1件: Rituximab1件: D02994 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 46
50Mabthéra----2件: 35, 162
51Macimorelin1件: Macimorelin1件: D10563 1件: GHSR 💬3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78
52MACIMORELIN ACETATE2件: Acetate,
Macimorelin		1件: D10563 1件: GHSR 💬3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78
53Macimorelin Consilient Health1件: Macimorelin1件: D10563 1件: GHSR 💬3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78
54Macimorelina----1件: 78
55Macitentan1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 51, 85, 86, 88, 210
56Macitentan (ACT-064992)1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
57Macitentan 10 mg1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 51, 86, 88
58Macitentan 10 mg tablet, once daily.1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
59Macitentan 10mg1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 51, 88
60Macitentan 3 mg1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
61Macitentan 37.5 mg1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
62Macitentan 3mg1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 51
63Macitentan 75 mg1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
64MACITENTAN COMPRESSE1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88
65Macitentan Group1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86
66MACITENTAN TABLETS1件: Macitentan1件: D10135 2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 86, 88
67Macrilen1件: Macimorelin1件: D10563 1件: GHSR 💬3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 78
68Macrogol1件: Polyethylene glycol1件: D03370 --1件: 299
69Macrogol 40001件: Polyethylene glycol1件: D03370 --1件: 299
70Madeos----1件: 301
71Madopar----1件: 6
72Madopar 125 mg T, tablets----1件: 6
73Madopar 125 mg, orodispersible tablet----1件: 6
74Madopar 200+50 mg----1件: 6
75Madopar LT----1件: 6
76Madopar monotherapy----1件: 6
77Madopar Tab. 125 or Perkin Tab. 25-100mg----1件: 6
78Madopar® 125----1件: 6
79Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride)2件: Benserazide,
Levodopa		2件: D00059 ,
D03082 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
80Madopar® 250----1件: 6
81Madopar® HBS----1件: 6
82Madopar® HBS 125----1件: 6
83MAG-DHA----1件: 299
84Magnesiocard 2.5mmol----1件: 298
85Magnesium1件: Magnesium---15件: 6, 11, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298
86Magnesium aspartate2件: Magnesium,
Magnesium aspartate		1件: D02026 --1件: 298
87MAGNESIUM ASPARTATE HYDROCHLORIDE3件: Magnesium,
Magnesium aspartate,
Magnesium aspartate hydrochloride		1件: D02026 --1件: 298
88Magnesium citrate2件: Magnesium,
Magnesium citrate		1件: D03265 --1件: 97
89Magnesium gluconate2件: Magnesium,
Magnesium gluconate		1件: D04835 --2件: 296, 297
90Magnesium hydroxide3件: Hydroxide ion,
Magnesium,
Magnesium hydroxide		1件: D00731 --1件: 284
91Magnesium oxide2件: Magnesium,
Magnesium oxide		1件: D01167 --3件: 6, 166, 291
92Magnesium sulfate3件: Magnesium gluconate,
Magnesium sulfate,
Sulfate ion		2件: D01108 ,
D04835 		--3件: 11, 296, 297
93Magnesium with ropivacaine2件: Magnesium,
Ropivacaine		1件: D08490 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70
94Maltodextrin1件: Maltodextrin1件: D02329 --4件: 6, 13, 96, 97
95Maltose1件: Maltose1件: D00044 --2件: 96, 97
96Mangafodipir1件: Mangafodipir1件: D08262 --1件: 13
97Mangafodipir (Teslascan)1件: Mangafodipir1件: D08262 --1件: 13
98Mango1件: Mango---2件: 96, 97
99Mango polyphenolics1件: Mango---2件: 96, 97
100Mannite1件: Mannitol1件: D00062 --1件: 299
101Mannitol1件: Mannitol1件: D00062 --7件: 6, 13, 28, 60, 96, 113, 299
102Mannitol + pulmozyme2件: Dornase alfa,
Mannitol		2件: D00062 ,
D03896 		--1件: 299
103Mannitol Inhalant Product1件: Mannitol1件: D00062 --1件: 299
104Mannitol inhalation powder1件: Mannitol1件: D00062 --1件: 299
105MANNITOLO 18%----1件: 2
106MANNITOLO 18% LDB----1件: 2
107Mannose1件: Mannose---2件: 13, 256
108MANTADAN*20CPR 100MG----1件: 13
109MANTADIX----1件: 6
110Manufacturerd by Cambridge Therapeutic Antibody Centre, Burroughs Wellcome, Glaxo Wellcome)----1件: 46
111Maralixibat1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
112Maralixibat (formely SHP625 or LUM001)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
113Maralixibat (formerly SHP625 or LUM001)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338
114Maralixibat (in precedenza SHP625 o LUM001)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338
115MARALIXIBAT CHLORIDE2件: Chloride ion,
Maralixibat		1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬3件: 296, 297, 338
116Maralixibat cloruro1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬2件: 296, 338
117Maraviroc1件: Maraviroc1件: D06670 1件: CCR5 💬11件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬2件: 46, 84
118Mare´s milk----2件: 96, 97
119Marijuana1件: Medical Cannabis---1件: 13
120Marketed plasma-derived VWF/FVIII concentrate----1件: 288
121MARS----1件: 6
122Masitinb mesylate----1件: 13
123MASITINIB1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96
124Masitinib (3.0)1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 2
125Masitinib (4.5)1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 13
126Masitinib (6.0)1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 2
127Masitinib (AB1010)1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 46
128Masitinib 100 mg Tablets1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 2
129Masitinib 100mg1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 5
130Masitinib 200 mg Tablets1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 2
131Masitinib 200mg1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 5
132Masitinib 3 mg1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 46
133Masitinib 6.0 mg1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬1件: 46
134Masitinib mesilate1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 13
135MASITINIB MESYLATE1件: Masitinib1件: D10229 1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96
136MASP-2 antibody1件: Narsoplimab1件: D11531 1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬3件: 64, 66, 109
137MASP-2 Antibody, OMS00620646, OMS6206461件: Narsoplimab1件: D11531 1件: MASP2 💬3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬1件: 66
138Mastinib----1件: 13
139Matched isoglycemic clamp----1件: 299
140Maternal Hyperoxygenation----1件: 211
141Mathéra----2件: 35, 162
142MATRICARIA FLOWER1件: Chamomile1件: D09212 --1件: 97
143MATRICARIA RECUTITA L. FLOS----1件: 97
144Matyrapone----1件: 75
145MAVACAMTEN1件: Mavacamten1件: D12265 1件: MYH7 💬7件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬1件: 58
146MAVENCLAD1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
147MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
148MAVENCLAD 10 mg tablets1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
149Mavenclad tabletter 10 mg1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
150Mavenclad®1件: Cladribine1件: D01370 1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13
151Mavoglurant1件: Mavoglurant---2件: 6, 206
152Mavorixafor----1件: 65
153MAVRILIMUMAB1件: Mavrilimumab1件: D09930 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 41, 46
154Mavrilimumab 10 mg1件: Mavrilimumab1件: D09930 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
155Mavrilimumab 100 mg1件: Mavrilimumab1件: D09930 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
156Mavrilimumab 150 mg1件: Mavrilimumab1件: D09930 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
157Mavrilimumab 30 mg1件: Mavrilimumab1件: D09930 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
158Mavrilimumab 50 mg1件: Mavrilimumab1件: D09930 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 46
159Maxidex----1件: 53
160Maximal oral 5ASA----1件: 97
161MAXOMAT ®, biosynthetic growth hormone1件: Somatotropin---1件: 195
162Maxtrex----1件: 46
163Mayzent1件: Siponimod1件: D11460 2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
164Mayzent 0,25 mg Filmtabletten1件: Siponimod1件: D11460 2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
165Mayzent 0.25 mg fi1件: Siponimod1件: D11460 2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
166Mayzent 2 mg film-coated tablets1件: Siponimod1件: D11460 2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
167Mayzent 2 mg Filmtabletten1件: Siponimod1件: D11460 2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13
168MB-102----1件: 96
169MBM-01----1件: 65
170MBP----1件: 13
171MBP peptide----1件: 13
172MBP8298----1件: 13
173MBP8298 Synthetic Peptide----1件: 13
174MBS2320----1件: 46
175MBS2320 20 mg----1件: 46
176MBS2320 40 mg----1件: 46
177MBS2320 5 mg----1件: 46
178MBX 8025----1件: 93
179MBX-8025----3件: 79, 93, 94
180MBX-8025 50 mg (Dose Escalation Period 1)----1件: 79
181MBX-8025 50 mg or 100 mg (Dose Escalation Period 2)----1件: 79
182MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3)----1件: 79
183MBX-8025, DSIC----1件: 93
184MBX-8025, Formulation 2----1件: 93
185MC1----1件: 6
186MCI-186----1件: 2
187MCI-186 in open label phase----1件: 2
188MCT----2件: 6, 296
189MCT powder----1件: 296
190MCTLs----1件: 65
191MD-0901----1件: 97
192MD-711----1件: 86
193MD1003----5件: 2, 10, 13, 14, 20
194MD1003 100 mg capsule----1件: 20
195MD1003 100mg capsule----1件: 13
196MDA----1件: 46
197MDGN-002----1件: 96
198MDX-1100----3件: 46, 96, 97
199MDX-1100 (anti-CXCL10 human monoclonal antibody)----1件: 97
200MDX-1342----1件: 46
201ME2080 (stiripentol)1件: Stiripentol1件: D05928 --1件: 140
202ME2125 (safinamide mesilate)1件: Safinamide1件: D10158 1件: MAOB 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
203Measles, Mumps, Rubella vaccination----1件: 107
204Mecasermin1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬5件: 78, 96, 168, 265, 299
205Mecasermin [rDNA Origin] 10mg/ml solution1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 96
206MECASERMINA1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 78
207Mecobalamin1件: Mecobalamin1件: D03246 --2件: 2, 70
208MEDI 545----1件: 49
209MEDI-522----1件: 46
210MEDI-545----2件: 49, 50
211MEDI-545 600----1件: 49
212MEDI-546----2件: 49, 51
213MEDI-551----2件: 13, 51
214MEDI-551 100 MG-IV----1件: 13
215MEDI-551 30 MG-IV----1件: 13
216MEDI-551 300 MG-SC----1件: 13
217MEDI-551 60 MG-SC----1件: 13
218MEDI-551 600 MG-IV----1件: 13
219MEDI-563----5件: 44, 45, 98, 162, 299
220MEDI-570 0.03 MG----1件: 49
221MEDI-570 0.1 MG----1件: 49
222MEDI-570 0.3 MG----1件: 49
223MEDI-570 1 MG----1件: 49
224MEDI1341----1件: 6
225MEDI2070----2件: 96, 97
226MEDI4920----1件: 53
227MEDI5117----1件: 46
228MEDI7183 high dose----1件: 97
229MEDI7183 low dose----1件: 97
230MEDI7183 medium dose----1件: 97
231MEDI7734----1件: 50
232MEDI99291件: Tezepelumab1件: D11771 1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98
233MEDI9929 anti-TSLP mAb (AMG157)1件: Tezepelumab1件: D11771 1件: TSLP 💬2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬1件: 98
234MediCabilis CBD Oil----1件: 2
235Medical air2件: Medical air,
Oxygen		1件: D00003 --3件: 85, 86, 193
236Medical air (sham O2)2件: Medical air,
Oxygen		1件: D00003 --1件: 85
237Medical Air vs Oxygen2件: Medical air,
Oxygen		1件: D00003 --1件: 193
238Medical Cannabis1件: Medical Cannabis---3件: 6, 96, 97
239Medical Grade Oxygen1件: Oxygen1件: D00003 --1件: 299
240Medical Marijuana1件: Medical Cannabis---1件: 13
241Medical Standard of Care for ITP----1件: 63
242Medication to suppress the immune system----1件: 19
243Medicinal air----1件: 149
244Medicine----1件: 2
245Medikinet----1件: 240
246Mediterranean diet supplemented with medium-chain triglyceride oil----1件: 6
247Medium chain triglyceride1件: Medium-chain triglycerides---1件: 318
248Medium chain triglycerides----1件: 96
249Medium dose prednisolone1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
250Medium dose TSO----1件: 96
251Medium Dose-VIS649----1件: 66
252Medium THC/medium CBD----1件: 46
253Medrol----4件: 13, 46, 56, 222
254MEDROL - 4 MG COMPRESSE 30 COMPRESSE----1件: 56
255Medrol 4 mg tablets1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
256Medrol A 16 mg tablets1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
257MEDROL*10CPR DIV 4MG1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
258Medrone----4件: 46, 51, 83, 162
259Medroxyprogesterone----1件: 49
260MEFLOQUINE1件: Mefloquine1件: D04895 --2件: 25, 46
261Megadose oral methylprednisolone1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
262Megestrol acetate2件: Acetate,
Megestrol acetate		1件: D00952 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76
263Megestrol Acetate Tablet2件: Acetate,
Megestrol acetate		1件: D00952 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 76
264Meglumine1件: Meglumine1件: D01796 --1件: 28
265MEK162----2件: 58, 195
266Mekinist1件: Trametinib1件: D10175 2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬2件: 34, 280
267Melarsoprol1件: Melarsoprol1件: D00832 --1件: 65
268Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d2件: Eflornithine,
Melarsoprol		2件: D00832 ,
D07883 		1件: ODC1 💬3件: Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬1件: 65
269Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d2件: Melarsoprol,
Nifurtimox		2件: D00832 ,
D00833 		--1件: 65
270Melatonin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202
271Melatonin CR1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202
272Melatonin PR1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6
273Melatonin(Circadin®)1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 6
274Melevodopa1件: Melevodopa1件: D07304 --1件: 6
275Melevodopa and decarboxylase inhibitor1件: Melevodopa1件: D07304 --1件: 6
276MELFLUFEN1件: Melphalan flufenamide1件: D11865 --1件: 28
277MELISSAE FOLII DRY AQUEOUS EXTRACT----1件: 97
278Melissenblätter 15ml/10ml----1件: 97
279Melitracen1件: Melitracen1件: D08171 --1件: 97
280Meloxicam1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 46, 49, 271, 296
281Meloxicam 0.125 mg/kg1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
282Meloxicam 0.25 mg/kg1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
283Meloxicam ampoule1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
284Meloxicam oral suspension1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
285Meloxicam suppository1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271
286Meloxicam tablet1件: Meloxicam1件: D00969 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271
287Melperon----1件: 6
288Melperone1件: Melperone1件: D07309 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
289Melperone HCl1件: Melperone1件: D07309 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
290Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
291Melphalan fulfenamide hydrochloride1件: Melphalan1件: D00369 --1件: 28
292Melphalan Hydrochloride1件: Melphalan1件: D00369 --1件: 60
293Melphalan, thalidomide and dexamethasone3件: Dexamethasone,
Melphalan,
Thalidomide		3件: D00292 ,
D00369 ,
D00754 		2件: NR3C1,
TNF 💬		68件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 28
294Melphalan-Flufenamide (Melflufen)2件: Melphalan,
Melphalan flufenamide		2件: D00369 ,
D11865 		--1件: 28
295Memantin Orion----1件: 6
296Memantine1件: Memantine1件: D08174 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 2, 6, 8, 13, 49, 127, 205, 206
297Memantine (drug)1件: Memantine1件: D08174 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 6
298Memantine (Ebixa)1件: Memantine1件: D08174 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 2
299MEMANTINE HYDROCHLORIDE1件: Memantine1件: D08174 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 127
300Memantine Hydrochloride Oral Solution1件: Memantine1件: D08174 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 2
301Menadiol Diphosphate1件: Menadiol diphosphate1件: D08176 --1件: 299
302Menadiol sodium diphosphate1件: Kappadione1件: D04908 --1件: 299
303Menatetrenone1件: Menatetrenone1件: D00100 --1件: 66
304MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11
305MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11
306MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11
307MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11
308MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN2件: Corynebacterium diphtheriae,
Corynebacterium diphtheriae CRM197 protein		---1件: 11
309Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)----1件: 13
310Menitorix----1件: 13
311Menjugate----1件: 14
312Mensa----1件: 96
313MENTHA × PIPERITA L. FOLIUM----1件: 97
314Menveo1件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine---6件: 11, 13, 61, 62, 66, 222
315MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC1件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine---2件: 62, 66
316MENVEO – Polvere e soluzione per soluzione iniettabile1件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine---2件: 61, 62
317MEOPA1件: Nitrous oxide1件: D00102 --1件: 149
318Meperizumab injection----1件: 44
319MEPOLIZUMAB1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬4件: 44, 45, 98, 162
320Mepolizumab (a-IL-5 antibody)1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 162
321Mepolizumab 100 mg1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 98
322Mepolizumab 300 mg1件: Mepolizumab1件: D04923 1件: IL5 💬13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬1件: 98
323Mepsevii1件: Vestronidase alfa1件: D11004 1件: GUSB 💬8件: Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬1件: 19
324Mercaptamina1件: Cysteamine1件: D03634 --1件: 19
325Mercaptamine1件: Cysteamine1件: D03634 --1件: 19
326MERCAPTAMINE BITARTRATE1件: Cysteamine1件: D03634 --1件: 19
327MERCAPTAMINE HYDROCHLORIDE1件: Cysteamine1件: D03634 --1件: 19
328Mercaptamine, mercamine, 2-aminoethanethiol1件: Cysteamine1件: D03634 --1件: 19
329Mercaptopurine1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬4件: 65, 96, 97, 164
330Mercaptopurine (Puri-Nethol)1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 97
331Mercaptopurine (Purinethol)1件: Mercaptopurine2件: D00161 ,
D04931 		1件: HPRT1 💬4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 97
332Meriva----1件: 46
333MEROPENEM1件: Meropenem2件: D02222 ,
D08185 		--2件: 60, 299
334Meropenem Fresenius Kabi1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
335Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
336Meropenem Infusion1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
337MEROPENEM TRIHYDRATE1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
338Mesalamin----1件: 97
339Mesalamine1件: Mesalazine1件: D00377 --4件: 96, 97, 98, 164
340Mesalamine Delayed Release Tablets 400mg2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
341Mesalamine Enema1件: Mesalazine1件: D00377 --1件: 97
342Mesalamine Granules1件: Mesalazine1件: D00377 --1件: 97
343Mesalamine Once-Daily1件: Mesalazine1件: D00377 --1件: 97
344Mesalamine Oral Product1件: Mesalazine1件: D00377 --1件: 98
345Mesalamine Twice-Daily1件: Mesalazine1件: D00377 --1件: 97
346Mesalamine, 5-aminosalicylic acid2件: Aminosalicylic acid,
Mesalazine		2件: D00162 ,
D00377 		--1件: 96
347Mesalamine, 5-aminosalicylic acid [5-ASA]2件: Aminosalicylic acid,
Mesalazine		2件: D00162 ,
D00377 		--1件: 97
348Mesalamine, 5-ASA1件: Mesalazine1件: D00377 --1件: 97
349MESALAZINA1件: Mesalazine1件: D00377 --1件: 97
350Mesalazine1件: Mesalazine1件: D00377 --3件: 46, 96, 97
351Mesalazine (3,600 mg)1件: Mesalazine1件: D00377 --1件: 97
352Mesalazine (Asacol®)1件: Mesalazine1件: D00377 --1件: 97
353Mesalazine (Mesalamine)1件: Mesalazine1件: D00377 --1件: 96
354Mesalazine - TID 1000 mg1件: Mesalazine1件: D00377 --1件: 97
355Mesalazine - TID 2x 500 mg1件: Mesalazine1件: D00377 --1件: 97
356Mesalazine 1000 mg gastro-resistant tablets1件: Mesalazine1件: D00377 --1件: 97
357Mesalazine 250Mg1件: Mesalazine1件: D00377 --1件: 97
358Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet2件: Mesalazine,
Nitazoxanide		2件: D00377 ,
D02486 		--1件: 97
359Mesalazine 4G Enema1件: Mesalazine1件: D00377 --1件: 97
360Mesalazine 500 mg gastro-resistant tablets (Salofa1件: Mesalazine1件: D00377 --1件: 97
361Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg)1件: Mesalazine1件: D00377 --1件: 97
362Mesalazine EC 500 mg1件: Mesalazine1件: D00377 --1件: 96
363Mesalazine Enema1件: Mesalazine1件: D00377 --1件: 97
364Mesalazine liquid enema1件: Mesalazine1件: D00377 --1件: 97
365Mesalazine slow-release granules1件: Mesalazine1件: D00377 --1件: 97
366Mesalazine Sustained-Release Tablets1件: Mesalazine1件: D00377 --1件: 96
367Mesalazine tablet1件: Mesalazine1件: D00377 --1件: 97
368Mesalazine tablets1件: Mesalazine1件: D00377 --1件: 96
369Mesalazine with hydrocortisone sodium succinate2件: Hydrocortisone,
Mesalazine		2件: D00088 ,
D00377 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
370Mesalazine, Tripterygium glycosides2件: Mesalazine,
Tripterygium wilfordii whole		1件: D00377 --1件: 96
371Mesalazinum1件: Mesalazine1件: D00377 --1件: 97
372Mesdopetam1件: Mesdopetam---1件: 6
373Mesdopetam (IRL790)1件: Mesdopetam---1件: 6
374Mesencephalic Neuronal Precursor Cells----1件: 6
375Mesenchymal cell and fibroblast injection----1件: 96
376Mesenchymal cell transplantation----2件: 46, 96
377MESENCHYMAL CELLS----1件: 97
378Mesenchymal stem cell----2件: 2, 93
379Mesenchymal stem cell 0.5----1件: 228
380Mesenchymal stem cell 1.0----1件: 228
381Mesenchymal stem cells----11件: 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299
382Mesenchymal stem cells (MSC)----3件: 2, 13, 96
383Mesenchymal stem cells (MSCs)----4件: 13, 36, 96, 97
384Mesenchymal stem cells derived from bone marrow (BM-MSCs)----1件: 36
385Mesenchymal Stem Cells extracted from bone marrow----1件: 36
386Mesenchymal Stem Cells from Wharton ´s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ´s jelly----1件: 51
387Mesenchymal stem cells isolated from Wharton's jelly----1件: 2
388Mesenchymal stem/stromal cells----1件: 13
389Mesenchymal Stromal Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---10件: 2, 36, 49, 51, 60, 96, 97, 107, 274, 284
390Mesenchymal stromal cells (MSC) for infusion1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 96
391Mesna1件: Coenzyme M---10件: 11, 13, 44, 45, 51, 60, 65, 85, 96, 164
392Mestinon1件: Pyridostigmine---3件: 3, 6, 11
393MET-2----1件: 97
394Metabolic balance measurements1件: Isoxaflutole---1件: 81
395Metabolic profile----1件: 113
396Metafolin----1件: 201
397Metalcaptase----1件: 171
398Metalcaptase® 150 mg gastro-resistant tablet----1件: 171
399Metalcaptase® 300 mg gastro-resistant tablet----1件: 171
400Metazym----1件: 19
401Metex----2件: 13, 46
402Metex 10 mg/ml Injektionslösung, Fertigspritze----1件: 46
403Metex 10mg Tabletten----1件: 46
404Metex 2,5 mg Tabletten----1件: 44
405Metex 2,5mg Tabletten----1件: 46
406Metex 50 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte----1件: 46
407Metex 7,5mg Tabletten----1件: 46
408Metex Pen----1件: 46
409Metex®----1件: 46
410Metex® 50 mg/ml Injektionslösung, Fertigspritze----1件: 46
411Metformin1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
412Metformin (generic)1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 158
413MetFORMIN 1000 Mg Oral Tablet1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13
414Metformin 500 Mg Oral Tablet, up to 4 tablets a day1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13
415Metformin 500 mg TID Oral Tablet1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 97
416Metformin 500mg1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
417Metformin and clemastine in combination2件: Clemastine,
Metformin		2件: D03535 ,
D04966 		3件: HRH1,
PRKAA1,
PRKAA2 💬		23件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Calcium signaling pathway, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Inflammatory mediator regulation of TRP channels, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13
418Metformin and Metformin & L-Citrulline2件: Citrulline,
Metformin		1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
419Metformin HCl1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 285
420METFORMIN HYDROCHLORIDE1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301
421Metformin treatment1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46
422Metformin XR1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 67
423Metformin/CP-690,5501件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46
424METFORMINA1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬2件: 67, 113
425METFORMINA - 500 30 COMPRESSE 500 MG1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 113
426Metformine1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬3件: 46, 81, 299
427METFORMINE ARROW 500mg1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 46
428Metformine HCL 500 PCH1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 299
429Metformine Sandoz 850 mg filmomhulde tabletten1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 81
430Methane1件: Methane---1件: 2
431Methelphenidate----1件: 13
432Methimazole1件: Methimazole1件: D00401 1件: TPO 💬4件: Autoimmune thyroid disease, Metabolic pathways, Thyroid hormone synthesis, Tyrosine metabolism 💬1件: 50
433Methionine1件: Methionine1件: D00019 --6件: 34, 84, 93, 229, 298, 300
434Methorexate----1件: 46
435Methotrexaat----1件: 46
436Methotrexat1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬4件: 13, 46, 50, 96
437Methotrexat 2,5 mg Tabletten medac1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
438Methotrexat HEXAL® 2,5 mg Tabletten1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
439Methotrexat Lachema 2,5mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
440Methotrexat Lachema 2,5mg tbl.1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
441Methotrexat Lachema 5 inj. sol1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
442METHOTREXAT Lederle - Tabletten1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
443Methotrexat Lederle 2.5mg tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
444Methotrexate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331
445Methotrexate 'Lederle' 2,5mg tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
446Methotrexate 'Lederle' 2.5mg Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
447Methotrexate 'Lederle' Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
448Methotrexate (Metoject® prefilled pen)1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
449Methotrexate (MTX)1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
450Methotrexate (stable dose)1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
451Methotrexate (tapering dose)1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
452Methotrexate + Infliximab2件: Infliximab,
Methotrexate		2件: D00142 ,
D02598 		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
453Methotrexate + Methylprednisolone2件: Methotrexate,
Methylprednisolone		2件: D00142 ,
D00407 		3件: DHFR,
DHFR2,
NR3C1 💬		6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬1件: 46
454METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 96
455Methotrexate - Amneal1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
456Methotrexate - DAVA1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
457Methotrexate - Delay1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
458Methotrexate - etanercept - prednisolone arm3件: Etanercept,
Methotrexate,
Prednisolone		3件: D00142 ,
D00472 ,
D00742 		5件: DHFR,
DHFR2,
LTA,
NR3C1,
TNF 💬		72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 107
459Methotrexate - Immediate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
460Methotrexate 10 mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
461Methotrexate 10 mg tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
462Methotrexate 2.5 mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44
463METHOTREXATE 2.5 mg tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
464Methotrexate 2.5mg Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
465Methotrexate 2.5mg Tablets BP1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
466Methotrexate 25 mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44
467Methotrexate 50mg/ml solution for injection, pre-filled syringe1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
468Methotrexate ``Lederle`` 2.5mg tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
469Methotrexate alone1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 107
470Methotrexate and folic acid2件: Folic acid,
Methotrexate		2件: D00070 ,
D00142 		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 49
471Methotrexate as methotrexate disodium1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
472Methotrexate bellon1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 97
473Methotrexate bellon 25mg/ml1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 97
474Methotrexate capsules1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
475METHOTREXATE DISODIUM1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬5件: 46, 96, 97, 107, 271
476Methotrexate Ebewe1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
477METHOTREXATE HOSPIRA 2,5 mg tablety1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
478METHOTREXATE HOSPIRA 2.5 mg tablety1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
479Methotrexate injection1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 96, 97
480Methotrexate Lachema 5inj. sol1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
481Methotrexate Lederle 2.5 mg Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
482Methotrexate Pfizer 2,5 mg tabletter1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
483Methotrexate Placebo1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
484Methotrexate plus ENBREL or ENBREL alone1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
485Methotrexate plus ERB-041 for 12 weeks1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
486Methotrexate plus sulfasalazine2件: Methotrexate,
Sulfasalazine		2件: D00142 ,
D00448 		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
487Methotrexate pre-filled pen1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
488Methotrexate prefilled pen1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
489Methotrexate prefilled syringe1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
490METHOTREXATE SODIUM1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 46, 256
491Methotrexate Sodium 2.5mg Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
492Methotrexate Sodium Tablets 2.5 mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
493Methotrexate Sodium Tablets 2.5mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
494Methotrexate Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 40, 46
495Methotrexate tablets 2.5 mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
496Methotrexate treatment1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 41, 46
497Methotrexate Wyeth 2,5mg1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
498Methotrexate Wyeth 2,5mg tbl.1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
499Methotrexate ® 2.5mg Tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
500Methotrexate(MTX)1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
501Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
502Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
503Methotrexate(necessary)1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
504METHOTREXATE*100CPR 2,5MG1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
505METHOTREXATE*10MG/1,33ML 4S1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
506METHOTREXATE*15MG/2ML 4SIR1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
507METHOTREXATE*2,5MG 25CPR1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
508METHOTREXATE*20MG/2,66ML 4S1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
509METHOTREXATE*25CPR 2,5MG1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 46, 107
510METHOTREXATE*7,5MG/ML 4SIR.1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
511Methotrexate, Leucovorin and BMS-9861423件: BMS-986142,
Leucovorin,
Methotrexate		3件: D00142 ,
D07986 ,
D07987 		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
512Methotrexate,Adalimumab2件: Adalimumab,
Methotrexate		2件: D00142 ,
D02597 		3件: DHFR,
DHFR2,
TNF 💬		71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
513Methotrexate-Lachema1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
514Methotrexate-Sulfasalazine-Hydroxychloroquine3件: Hydroxychloroquine,
Methotrexate,
Sulfasalazine		3件: D00142 ,
D00448 ,
D08050 		2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
515Methotrexate® 2.5 mg tablets1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
516Methotrextate----1件: 46
517Methoxsalen1件: Methoxsalen1件: D00139 --3件: 36, 46, 96
518Methoxsalen +ECP1件: Methoxsalen1件: D00139 --1件: 96
519Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-beta-Dribofuronamide1件: Adenine1件: D00034 --1件: 46
520Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-ß-Dribofuronamide1件: Adenine1件: D00034 --1件: 46
521Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo----1件: 86
522Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb----2件: 86, 88
523Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth----2件: 86, 88
524Methyl Prednisolonate----1件: 13
525Methyl prednisolone1件: Prednisolone1件: D00472 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 43, 49, 96
526Methylaminopterin----1件: 46
527Methylcobalamin1件: Mecobalamin1件: D03246 --1件: 2
528METHYLENE BLUE1件: Methylene blue2件: D02312 ,
D10537 		--1件: 97
529Methylene blue 25mg tablets1件: Methylene blue2件: D02312 ,
D10537 		--1件: 97
530Methylenetetrahydrofolate reductase (MTHFR) deficiency----1件: 337
531Methylmalonyl-coenzyme A2件: (R)-methylmalonyl-CoA,
Coenzyme A		---1件: 246
532Methyloprednisolone----1件: 13
533Methylorednisolone----1件: 56
534Methylphenidate1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206
535Methylphenidate (MPD)1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 6
536Methylphenidate (overencapsulated)1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84
537Methylphenidate 10mg tablets1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 84
538METHYLPHENIDATE HYDROCHLORIDE1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13
539Methylphenidate modified release1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
540Methylphenidate modified release 20 mg1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
541Methylphenidate modified release 30 mg1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
542Methylphenidate modified release 40 mg1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13
543Methylphenidate Oral Solution1件: Methylphenidate1件: D04999 2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 206
544Methylphenidate, fluoxetin, risperidone3件: Fluoxetine,
Methylphenidate,
Risperidone		3件: D00326 ,
D00426 ,
D04999 		5件: DRD2,
HTR2A,
SLC6A2,
SLC6A3,
SLC6A4 💬		14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬2件: 179, 206
545Methylphenylpyrazolone1件: Edaravone1件: D01552 --1件: 2
546Methylprednisolon1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 14, 51, 66
547Methylprednisolon (Solu-Medrol)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14
548Methylprednisolon-21-hydrogensuccinat, Natriumsalz1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
549Methylprednisolone1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
550Methylprednisolone (drug)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
551Methylprednisolone (MP)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 60, 285
552Methylprednisolone (MP) or prednisone (pred)2件: Methylprednisolone,
Prednisone		2件: D00407 ,
D00473 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
553Methylprednisolone (or other glucocorticoid)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 43
554Methylprednisolone (Solu-Medrol)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 14
555Methylprednisolone 1250 mg/24h x3 days1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
556METHYLPREDNISOLONE ACETATE2件: Acetate,
Methylprednisolone		1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 46, 51
557Methylprednisolone and azathioprine2件: Azathioprine,
Methylprednisolone		2件: D00238 ,
D00407 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 93, 95
558Methylprednisolone and Mycophenolate mofetil3件: Methylprednisolone,
Mycophenolate mofetil,
Mycophenolic acid		3件: D00407 ,
D00752 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬2件: 93, 95
559Methylprednisolone bolus IV 15 mg/kg/d for 3 days.1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
560Methylprednisolone hemisuccinate2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: D00407 ,
D05000 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
561Methylprednisolone IV1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
562METHYLPREDNISOLONE MYLAN Générique1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
563Methylprednisolone or budesonide2件: Budesonide,
Methylprednisolone		2件: D00246 ,
D00407 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 96
564Methylprednisolone or Prednisolone2件: Methylprednisolone,
Prednisolone		2件: D00407 ,
D00472 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 65
565Methylprednisolone PO1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
566Methylprednisolone pulse1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 66, 220
567METHYLPREDNISOLONE SODIUM HEMISUCCINATE1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97
568METHYLPREDNISOLONE SODIUM SUCCINATE1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬6件: 13, 46, 49, 50, 51, 211
569Methylprednisolone succinate2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: D00407 ,
D05000 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13
570Methylprednisolone(intravenously in the 1st-2nd-3rd month )1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
571Methylprednisolone(intravenously in the 1st-3rd-5th month)1件: Methylprednisolone1件: D00407 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
572Methylprednisoloni natrii succinas----1件: 50
573Methylprednisone1件: Methylprednisone---4件: 46, 66, 85, 222
574Methylprednisone/Prednisone2件: Methylprednisone,
Prednisone		1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 85
575Methylthioninium1件: Methylthioninium---1件: 127
576Methylthioninium chloride3件: Chloride ion,
Methylene blue,
Methylthioninium		2件: D02312 ,
D10537 		--1件: 127
577Metilprdnisolone----1件: 11
578METILPREDNISOLONE----6件: 11, 13, 53, 56, 63, 300
579METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO----1件: 300
580Metilprednisolone sodio succinato----3件: 13, 14, 56
581METOCLOPRAMIDE1件: Metoclopramide1件: D00726 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 46, 51
582METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL1件: Metoclopramide1件: D00726 1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 51
583MetoHEXAL® Succ ® 23,75 mg Retardtabletten----1件: 113
584MetoHEXAL® Succ ® 47,5 mg Retardtabletten----1件: 113
585MetoHEXAL® Succ ® 95 mg Retardtabletten----1件: 113
586METOJECT1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬6件: 41, 46, 96, 97, 107, 271
587Metoject 10 mg/ml1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 50
588METOJECT 10 mg/ml, solution injectable en seringue pré-remplie1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 44
589Metopirone1件: Metyrapone1件: D00410 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
590Metopirone 250 mg capsules1件: Metyrapone1件: D00410 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
591Metopirone 250 mg capsules/ Cormeto1件: Metyrapone1件: D00410 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
592Metopirone 250 mg capsules/Cormeto1件: Metyrapone1件: D00410 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
593Metoprolol1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 17, 57, 58, 113, 193, 226
594Metoprolol succinate1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 57, 58, 113, 193
595METOPROLOL SUCCINATE (PH. EUR.)1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 193
596Metoprolol succinate + doxazosin2件: Doxazosin,
Metoprolol		2件: D02358 ,
D07874 		4件: ADRA1A,
ADRA1B,
ADRA1D,
ADRB1 💬		13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 57
597Metoprolol tartrate 50 mg1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 17
598Metoprolol Tartrate Oral Tablet1件: Metoprolol1件: D02358 1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 226
599Metoprololsuccinat----1件: 58
600Metoprololsuccinat Orion 25mg----1件: 193
601Metoprololsuccinat ”Orion” 25mg----1件: 193
602Metotab®----1件: 46
603METOTRESSATO SALE SODICO----1件: 46
604Metotrexat----2件: 50, 96
605Metotrexat Orion----1件: 46
606Metotrexate----1件: 50
607METOTREXATO1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬2件: 46, 107
608METOTREXATO SANDOZ - 2.5 MG COMPRESSE 50 COMPRESSE IN FLACONE PP1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
609METOTREXATO SODICO1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
610METOTREXATO SODIO1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
611METOTREXATO-LEDERLE 2,5 MG COMPRIMIDOS1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
612METRELEPTIN1件: Metreleptin1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
613Metrelpetin----1件: 265
614Metronidazol1件: Metronidazole1件: D00409 --2件: 46, 96
615METRONIDAZOLE1件: Metronidazole1件: D00409 --7件: 46, 51, 63, 94, 96, 97, 291
616Metronidazole capsule 50 mg1件: Metronidazole1件: D00409 --1件: 97
617Metronidazole Oral1件: Metronidazole1件: D00409 --1件: 96
618METYRAPONE1件: Metyrapone1件: D00410 1件: CYP11B1 💬4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬1件: 75
619Metyyliprednisoloninatriumsuksinaatti----1件: 211
620Mexiletina1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114
621MEXILETINA CLORIDRATO1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114
622Mexiletine1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 1, 2, 10, 113, 114
623Mexiletine 167 mg1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 113
624Mexitil1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114
625MEXITIL*20CPS 200MG1件: Mexiletine1件: D08215 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 114
626Mextrex----1件: 46
627Mezagitamab1件: Mezagitamab1件: D11945 1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬2件: 63, 66
628MEZAVANT1件: Mesalazine1件: D00377 --1件: 97
629Mezavant 1200 mg magensaftresistente Retardtabletten1件: Mesalazine1件: D00377 --1件: 97
630Mezavant Gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
631Mezavant XL1件: Mesalazine1件: D00377 --1件: 97
632Mezavant XL 1200 mg gastro-resistant prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
633Mezavant XL 1200 mg gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
634Mezavant XL 1200 mg gastro-resistant, prolonged release tablets.2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
635Mezavant XL 1200mg gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
636Mezavant XL Gastro-resistant, prolonged release tablets2件: Manganese citrate,
Mesalazine		1件: D00377 --1件: 97
637Mezym F----1件: 298
638Mg----5件: 6, 13, 51, 63, 111
639Mg++----1件: 6
640MG-O-1002----1件: 11
641MG-S-2525----1件: 85
642MG01CI extended-release tablet1件: Manganese citrate---1件: 206
643MGlu5 antagonist----1件: 206
644MH002----1件: 97
645MH004 Ia(0.1%)----1件: 46
646MH004 Ia(0.3%)----1件: 46
647MH004 Ia(1%)----1件: 46
648MH004 Ia(3%)----1件: 46
649MH004 Ib-1(0.1%)----1件: 46
650MH004 Ib-1(0.3%)----1件: 46
651MH004 Ib-1(1%)----1件: 46
652MH004 Ib-2(0.3%)----1件: 46
653MH004 Ib-2(1%)----1件: 46
654MH004 Ib-2(3%)----1件: 46
655MHS552----1件: 49
656MHSCT----1件: 51
657MHV370----2件: 52, 53
658Miacalcic----1件: 225
659MIB-626----1件: 18
660MIC----2件: 140, 144
661Micellar Paclitaxel for Injection1件: Paclitaxel1件: D00491 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬1件: 46
662MICOFENOLATO MOFETILE----1件: 53
663Micofenolato mofetilo----1件: 35
664MICOFENOLICO ACIDO1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49
665Microarray analysis----2件: 28, 285
666MICROBIOTA----1件: 96
667Microbiote fécal----1件: 97
668Microgynon----2件: 13, 51
669Microgynon®----1件: 13
670Microgynon® 30 (Oral contraceptive)----1件: 46
671Micropirin----1件: 13
672Mid dose ANAVEX2-73----1件: 6
673Midamor1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 225
674Midazolam1件: Midazolam1件: D00550 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
675Midazolam 3 mg1件: Midazolam1件: D00550 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 96
676Midazolam injection1件: Midazolam1件: D00550 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 21
677Midazolam Maleate Tablets1件: Midazolam1件: D00550 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 46
678Midodrine1件: Midodrine1件: D08220 3件: ADRA1A,
ADRA1B,
ADRA1D 💬		7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬3件: 6, 17, 58
679MIDODRINE HYDROCHLORIDE1件: Midodrine1件: D08220 3件: ADRA1A,
ADRA1B,
ADRA1D 💬		7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 58
680Midodrine or atomoxetine pill2件: Atomoxetine,
Midodrine		2件: D07473 ,
D08220 		4件: ADRA1A,
ADRA1B,
ADRA1D,
SLC6A2 💬		8件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 17
681Mifedren----1件: 75
682MIFEPRISTONE1件: Mifepristone1件: D00585 2件: NR3C1,
PGR 💬		6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75
683MIGALASTAT1件: Migalastat1件: D10359 --1件: 19
684Migalastat HCl1件: Migalastat1件: D10359 --1件: 19
685Migalastat HCl 150 mg1件: Migalastat1件: D10359 --1件: 19
686MIGALASTAT HYDROCHLORIDE1件: Migalastat1件: D10359 --1件: 19
687Migalastat hydrocloride1件: Migalastat1件: D10359 --1件: 19
688MighTeaFlow----1件: 53
689MIGLUSTAT1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
690Miglustat (AT2221)1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 256
691MIGLUSTAT (ZAVESCA)1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬1件: 19
692MIL62----1件: 222
693Milatuzumab1件: Milatuzumab1件: D08944 1件: CD74 💬3件: Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis 💬1件: 49
694Mild dose cannabis1件: Medical Cannabis---1件: 13
695Milk1件: Cow milk---1件: 98
696Milnacipran1件: Milnacipran1件: D08222 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 46, 49
697Milrinone1件: Milrinone1件: D00417 2件: PDE3A,
PDE3B 💬		11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 294
698Miltenyi CliniMACS----1件: 285
699MIN-102----2件: 18, 20
700Mind-body therapy----1件: 168
701MINGO----1件: 120
702Minibody against CD8 conjugated to desferrioxamine labeled with zirconium Zr 891件: Deferoxamine1件: D03670 --2件: 51, 53
703Minirin1件: Desmopressin1件: D00291 2件: AVPR2,
F8 💬		4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬2件: 64, 288
704Minocycline1件: Minocycline1件: D05045 --13件: 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299
705Minocycline 100 mg Film-coated Tablets1件: Minocycline1件: D05045 --1件: 13
706Minocycline 100mg1件: Minocycline1件: D05045 --1件: 13
707Minocycline Hydrochloride1件: Minocycline1件: D05045 --4件: 13, 201, 206, 299
708Minocycline, then Minocycline/Lovastatin2件: Lovastatin,
Minocycline		2件: D00359 ,
D05045 		1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 206
709Minodronate1件: Minodronic acid---1件: 46
710Minodronic acid1件: Minodronic acid---4件: 6, 46, 93, 95
711Minomycin1件: Minocycline1件: D05045 --1件: 84
712MINOXIDIL1件: Minoxidil1件: D00418 2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬1件: 179
713Minrin----1件: 288
714Mipomersen1件: Mipomersen---1件: 79
715Mirabegron1件: Mirabegron1件: D09535 1件: ADRB3 💬8件: Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬4件: 6, 13, 53, 226
716Mirapex----1件: 6
717Mirapex (pramipexole)1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
718Mirapex ER----1件: 6
719Mirapex LA----1件: 6
720Mirapexin1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
721Mirapexin / Sifrol1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
722Mirapexin extended release various strengths2件: Manganese citrate,
Pramipexole		1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
723MIRAPEXIN*30CPR 0,7MG1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
724Mirapexin/Sifrol1件: Pramipexole1件: D05575 3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
725Mirdametinib1件: Mirdametinib1件: D11675 2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
726Mirdametinib (MEK Inhibitor)1件: Mirdametinib1件: D11675 2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
727Mirdametinib (PD-0325901) oral capsule or dispersible tablet1件: Mirdametinib1件: D11675 2件: MAP2K1,
MAP2K2 💬		89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34
728Miridesap1件: Miridesap1件: D11464 1件: APCS 💬-1件: 28
729Mirikizumab1件: Mirikizumab1件: D11123 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 37, 96, 97
730Mirikizumab IV1件: Mirikizumab1件: D11123 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97
731Mirikizumab SC1件: Mirikizumab1件: D11123 1件: IL23A 💬9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97
732MiRNA----1件: 13
733Mirogabalin1件: Mirogabalin1件: D11203 2件: CACNA2D1,
CACNA2D2 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬1件: 70
734MIS416----1件: 13
735Misoprostol1件: Misoprostol1件: D00419 3件: PTGER2,
PTGER3,
PTGER4 💬		9件: Calcium signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway 💬3件: 46, 70, 271
736Mitomycin1件: Mitomycin1件: D00208 --2件: 94, 329
737Mitomycin C1件: Mitomycin1件: D00208 --1件: 94
738MitoQ----3件: 6, 13, 97
739Mitoquinone1件: Mitoquinone---1件: 13
740Mitoxantrone1件: Mitoxantrone1件: D08224 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
741Mitoxantrone Hydrochloride Liposome Injection1件: Mitoxantrone1件: D08224 2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13
742Mizoribine1件: Mizoribine1件: D01392 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬8件: 46, 49, 51, 53, 66, 94, 222, 224
743MK-0653----1件: 260
744MK-0663----2件: 46, 271
745MK-0859----1件: 79
746MK-08731件: MK-0873---1件: 46
747MK-2225----1件: 51
748MK-3222----1件: 271
749MK-4836----2件: 86, 88
750MK-5475----1件: 86
751MK-6194----1件: 97
752MK-7962----1件: 86
753MK-8259----1件: 97
754MK-8457----1件: 46
755MK-8457 (free acid)----1件: 46
756MK-8457 100 mg----1件: 46
757MK-8808----1件: 46
758MK-8892----1件: 86
759MK0359----1件: 46
760MK0653, ezetimibe1件: Ezetimibe1件: D01966 1件: NPC1L1 💬1件: Fat digestion and absorption 💬1件: 260
761MK0657----1件: 6
762MK0663, etoricoxib1件: Etoricoxib1件: D03710 1件: PTGS2 💬22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46
763MK0812----2件: 13, 46
764MK0812 / Duration of Treatment: 12 Weeks----1件: 46
765MK0966----1件: 46
766MK8457----1件: 46
767MLN0002----3件: 94, 96, 97
768MLN0002 (Vedolizumab)1件: Vedolizumab1件: D08083 2件: ITGA4,
ITGB7 💬		15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬2件: 96, 97
769MLN0002 SC----2件: 96, 97
770MLN002----2件: 96, 97
771MLN1202----1件: 13
772MLN3897----1件: 46
773MLTA3698A1件: Pateclizumab1件: D10187 1件: LTA 💬7件: Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor 💬1件: 46
774MM-0931件: MM-093---1件: 46
775MMC----1件: 118
776MMF----16件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299
777MMF and Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 222
778MMX Mesalamine1件: Mesalazine1件: D00377 --1件: 97
779MMX mesalamine/ mesalazine1件: Mesalazine1件: D00377 --1件: 97
780MMX Mesalamine/Mesalazine1件: Mesalazine1件: D00377 --1件: 97
781MMX Mesalamine/Mesalazine (High Dose)1件: Mesalazine1件: D00377 --1件: 97
782MMX Mesalamine/Mesalazine (Low Dose)1件: Mesalazine1件: D00377 --1件: 97
783MN-001----1件: 226
784MN-001 BID----1件: 226
785MN-08 24 mg/day----1件: 86
786MN-08 60 mg/day----1件: 86
787MN-166----1件: 2
788MNC (Mononuclear cells)----1件: 2
789MNK-1411----1件: 113
790Mobilization of stem cells to prepare for Leukapheresis----1件: 96
791MOCLOBEMIDE1件: Moclobemide1件: D02561 1件: MAOA 💬14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6
792MOD-4023----1件: 78
793MODAFINIL1件: Modafinil1件: D01832 --4件: 6, 13, 49, 93
794Modafinil 50mg1件: Modafinil1件: D01832 --1件: 6
795Modal----2件: 6, 70
796Moderate doses of Thiamine y Biotin2件: Biotin,
Thiamine		2件: D00029 ,
D08580 		--1件: 8
797Moderate Oligosaccharide Group----1件: 96
798Moderna COVID-19 Vaccine1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 46
799Moderna mRNA-1273----7件: 13, 35, 46, 49, 50, 51, 107
800Moderna mRNA-1273, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107
801Modified Atkins diet----3件: 145, 157, 187
802Modified BiP----1件: 46
803Modified cobratoxin----1件: 20
804Modified Gegen Qinlian Decoction----1件: 97
805Modified lipid formulation----1件: 299
806Modified mRNA encoding human methylmalonyl-coenzyme A mutase2件: (R)-methylmalonyl-CoA,
Coenzyme A		---1件: 246
807Modified Oral Glucose Tolerance Test (50g 4-hours)1件: Dextrose, unspecified form---1件: 299
808Modified recombinant human c-type----1件: 276
809Modified recombinant human C-type natriuretic peptide----1件: 276
810MODIFIED RHCNP----1件: 276
811Modified-release phosphatidylcholine2件: Lecithin,
Manganese citrate		1件: D04682 --1件: 97
812Modified-thoracolumbar interfascial plane block----1件: 70
813Modiodal----1件: 6
814MODOPAR----1件: 6
815Modopar 125----1件: 6
816Modopar 62,5----1件: 6
817Modulen----1件: 96
818MODULEN IBD----1件: 96
819MODULEN IBD (R) (specific Enteral Nutrition)----1件: 96
820Moexipril1件: Moexipril1件: D08225 1件: ACE 💬6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 93
821MOG peptide----1件: 13
822Mogamulizumab1件: Mogamulizumab1件: D09761 1件: CCR4 💬5件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 26
823Molgramostim1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬3件: 97, 229, 299
824Molgramostim 300 mcg nebuliser solution1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229
825Molgramostim 300 µg nebulizer solution1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229
826Molgramostim Nebuliser solution 300 mcg1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229
827Molgramostim nebulizer solution1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 299
828MOLI 1901----1件: 299
829Moli 1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
830Moli1901----1件: 299
831Moli1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
832Mometasone1件: Mometasone1件: D08227 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162
833MOMETASONE FUROATE2件: Mometasone,
Mometasone furoate		2件: D00690 ,
D08227 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 98, 162
834MONARSEN1件: Monarsen---1件: 11
835Mongersen1件: Mongersen1件: D10956 1件: SMAD7 💬2件: Hippo signaling pathway, TGF-beta signaling pathway 💬2件: 96, 97
836MONITOR1件: Methamidophos---4件: 2, 11, 81, 129
837Mono Nuclear Cell (MNC) transplantation----1件: 57
838Mono-Therapy with Sildenafil1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 86
839Monoamine oxidase B inhibitors----1件: 6
840Monoclonal antibodies----1件: 96
841Monoclonal Antibody (MAb)----1件: 271
842Monoclonal antibody (Mab) sB24M----1件: 269
843MONOCLONAL ANTIBODY ANTI-IGG1----3件: 37, 96, 97
844Monoclonal antibody cA2----1件: 96
845Monoclonal antibody M-T412----1件: 13
846MONOCOR----1件: 67
847Monocytes and megacaryocytes culture and RNA extraction----1件: 113
848Monohydrate----1件: 107
849Monolaurin1件: Glyceryl laurate---1件: 160
850Monolaurin cream1件: Glyceryl laurate---1件: 160
851Monomethyl fumarate1件: Monomethyl fumarate1件: D11492 --1件: 13
852Monomethyl fumarate 190 mg1件: Monomethyl fumarate1件: D11492 --1件: 13
853Monores----1件: 1
854MONORES*30CPR 20MCG----1件: 1
855Monotherapy (Lopinavir/ritonavir)2件: Lopinavir,
Ritonavir		2件: D00427 ,
D01425 		--1件: 265
856Monotherapy (Lopinavir/ritonavir) + ABC/3TC2件: Lopinavir,
Ritonavir		2件: D00427 ,
D01425 		--1件: 265
857Monovalent [B.1.351] CoV2 preS dTM-AS03----7件: 13, 35, 46, 49, 50, 51, 107
858Montelukast1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬8件: 6, 13, 46, 61, 63, 85, 98, 228
859Montelukast Krka1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 6
860MONTELUKAST SODIUM1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 228
861Montelukast Teva1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 228
862Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-9861426件: BMS-986142,
Digoxin,
Flurbiprofen,
Midazolam,
Montelukast,
Pravastatin		5件: D00298 ,
D00330 ,
D00550 ,
D08229 ,
D08410 		24件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4,
CYSLTR1,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
HMGCR,
PTGS1,
PTGS2 💬		49件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46
863Montelukast/ Singulair1件: Montelukast1件: D08229 1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 98
864Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections1件: Human interleukin-2---1件: 2
865MOR03087----2件: 66, 222
866MOR103----2件: 13, 46
867MOR202----2件: 66, 222
868MORAb-022----1件: 46
869MORF-057----1件: 97
870Moringa Oleifera----1件: 46
871Morphine1件: Morphine1件: D08233 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬5件: 36, 46, 70, 85, 86
872Morphine Hexal1件: Morphine1件: D08233 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 46
873Morphine hydrochloride1件: Morphine1件: D08233 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 85
874Morphine PCA1件: Morphine1件: D08233 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70
875MORPHINE SULFATE2件: Morphine,
Sulfate ion		1件: D08233 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬3件: 46, 85, 86
876Morphine sulphate in intrasite gel1件: Morphine1件: D08233 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 36
877Morphinsulfat----1件: 46
878Mosapride1件: Mosapride1件: D08236 1件: HTR4 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬1件: 96
879Moss-aGal (recombinant human alpha-galactosidase A produced in moss)1件: Agalsidase alfa1件: D02784 1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
880Most recent vaccine to seasonal influenza----1件: 13
881Mosunetuzumab1件: Mosunetuzumab1件: D11463 2件: CD3E,
MS4A1 💬		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 49
882MOTILIUM----2件: 6, 230
883Movprep----1件: 96
884Moxifloxacin1件: Moxifloxacin1件: D08237 --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
885Moxifloxacin 400 mg1件: Moxifloxacin1件: D08237 --1件: 86
886Moxifloxacin Hydrochloride1件: Moxifloxacin1件: D08237 --2件: 113, 299
887Moxifloxacin infusion1件: Moxifloxacin1件: D08237 --1件: 6
888Mozobil1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬3件: 19, 65, 285
889MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 19
890MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
891Mozobil 20mg/mL vial (injectable solution for subcutaneous use)1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
892Mozobil 20mg/mL vial (injectable solution, subcutaneous use)1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
893Mozobil,1件: Plerixafor1件: D08971 1件: CXCR4 💬14件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬1件: 65
894MP and CTX----1件: 222
895MP-376----1件: 299
896MP-376 (Levofloxacin Solution for Inhalation)1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
897MP-435(dose1) + Methotrexate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
898MPA----8件: 13, 35, 46, 49, 50, 51, 60, 107
899MPC----2件: 210, 211
900MPH966----2件: 228, 231
901MQX-503----1件: 51
902MR Prednisone1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
903MR-MC-01----1件: 226
904MRA----2件: 46, 107
905MRA (Actemra)1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 107
906MRA (Tocilizumab)1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
907MRA 003 US----1件: 49
908MRA(Tocilizumab)1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
909MRA, Actemra1件: Tocilizumab1件: D02596 1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬2件: 46, 107
910MRA-SC----1件: 46
911MRC375----1件: 46
912MRC375 150mg----1件: 46
913MRI contrast-enhancing preparations----1件: 13
914MRI with PFP----1件: 299
915MRNA che codifica l’enzima umano deramificante del glicogeno formulato in una nanopaticella lipidica----1件: 257
916MRNA COVD19 vaccine----3件: 49, 53, 271
917MRNA encoding modified Ornithine transcarbamylase1件: Ornithine1件: D08302 --1件: 251
918MRNA encoding the human glycogen debranching enzyme----1件: 257
919MRNA encoding the human glycogen debranching enzyme formulated in a lipid nanoparticle delivery----1件: 257
920MRNA-3704----1件: 246
921MRNA-3705----1件: 246
922MRNA-3927----1件: 245
923MRT5005----1件: 299
924MRT5201----1件: 251
925MRX Drug Substance (formerly Maralixibat , SHP625 or LUM001)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338
926MRX Drug Substance (formerly Maralixibat, SHP625 or LUM001)1件: Maralixibat1件: D10951 2件: SLC10A1,
SLC10A2 💬		2件: Bile secretion, Hepatitis B 💬1件: 338
927MS-20 oral solution----1件: 97
928MS1819----2件: 298, 299
929MS1819-SD1件: MS-1819---2件: 298, 299
930MSB11022----1件: 46
931MSB11456----1件: 46
932MSC----6件: 6, 51, 60, 96, 97, 271
933MSC injection 01----1件: 96
934MSC injection 02----1件: 96
935MSC treatment----1件: 49
936MSC treatment 01----1件: 96
937MSC treatment 02----1件: 96
938MSC+ATG----1件: 60
939MSC-AFP----1件: 96
940MSC-NTF cells transplantation (IM)----1件: 2
941MSC-NTF cells transplantation (IT)----1件: 2
942MSC2015----1件: 13
943MSC2304479A----1件: 13
944MSC2304480A----1件: 13
945MSC2304481A----1件: 13
946MSC2304482A----1件: 13
947MSC2358825A----1件: 13
948MSC2364447C----2件: 13, 49
949MSC2430913A or ONO-4641 (to be used as synonyms)----1件: 13
950MSC2491529A----1件: 13
951MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF----1件: 2
952MSCs----1件: 228
953MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: D00746 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
954MSI-1995----1件: 299
955MSK-DA01----1件: 6
956MSTC-001 (MS-STAT)----1件: 13
957MT-1186----1件: 2
958MT-1303----3件: 13, 96, 97
959MT-1303 [0.1]----1件: 13
960MT-1303 [0.2]----1件: 13
961MT-1303 [0.4]----1件: 13
962MT-1303 High dose----1件: 49
963MT-1303 Low dose----1件: 49
964MT-1303-FormA----1件: 13
965MT-1303-FormB----1件: 13
966MT-1303-High----1件: 13
967MT-1303-Low----1件: 13
968MT-1303-Middle----1件: 13
969MT-3921----1件: 26
970MT-7117----2件: 51, 254
971MT-7117 High Dose----1件: 254
972MT-7117 Low Dose----1件: 254
973MT2031件: Namilumab---1件: 46
974MTC TRx0014-001 capsules----1件: 127
975MTP-131----1件: 21
976MTRX1011A----1件: 46
977MTT----1件: 299
978MTX----14件: 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271
979MTX 12.5----1件: 97
980MTX 25----1件: 97
981MTX Goldshield Tablets----1件: 46
982MTX HEXAL 2,5 mg Tabletten----1件: 46
983MTX HEXAL 2,5mg Tabletten----1件: 46
984MTX HEXAL Tablets----1件: 46
985MTX plus anti-TNF----1件: 46
986MTX start----1件: 46
987MTX therapy----1件: 46
988MTX-hold----1件: 46
989Mucoangin----1件: 19
990Mucoid exopolysaccharide P. aeruginosa immune globulin IV----1件: 299
991Mucolysin----1件: 299
992Mucomyst1件: Acetylcysteine1件: D00221 --1件: 299
993Mucosta----1件: 53
994Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH)1件: Tripterygium wilfordii whole---1件: 66
995Multi-modal pain management [Acetaminophen + Gabapentin]2件: Acetaminophen,
Gabapentin		2件: D00217 ,
D00332 		7件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
PTGS1,
PTGS2,
SLC6A1 💬		31件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway 💬1件: 70
996Multi-modal pain management [Fentanyl]1件: Fentanyl1件: D00320 1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70
997Multi-modal pain management [Intravenous Ketamine]1件: Ketamine1件: D08098 5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 70
998Multi-modal pain management [Valium + Gabapentin]1件: Gabapentin1件: D00332 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70
999Multi-strain probiotic----1件: 6
1000Multienzymes (lipase, protease etc.)----2件: 298, 299
1001Multiferon----1件: 13
1002Multigrain powder (S)----1件: 46
1003MultiHance1件: Gadobenic acid1件: D08018 --2件: 86, 88
1004Multimodal Bundle Drugs----1件: 226
1005Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)1件: Myelin basic protein---1件: 13
1006Multiple Dose----1件: 2
1007Multiple dose- Group B----1件: 97
1008Multiple dose-Group B----1件: 97
1009MultiStem1件: MultiStem---1件: 97
1010MultiStem high dose1件: MultiStem---1件: 97
1011MultiStem low dose1件: MultiStem---1件: 97
1012Multivitamin----1件: 49
1013Mupirocin1件: Mupirocin1件: D01076 --2件: 227, 299
1014Mupirocin Intranasal Creme1件: Mupirocin1件: D01076 --1件: 299
1015Muromonab1件: Muromonab---1件: 60
1016Muromonab-CD31件: Muromonab---1件: 60
1017Muscimol1件: Muscimol---1件: 6
1018Mushroom1件: Cultivated mushroom---2件: 6, 46
1019Mushroom extract1件: Cultivated mushroom---1件: 46
1020MuSK-CAART----1件: 11
1021Mussel oil capsules----1件: 46
1022Mutagrip----2件: 11, 13
1023Mutation Analysis----1件: 263
1024Mutation in the gene----1件: 8
1025MVA----1件: 96
1026MVA HAV----1件: 96
1027MXB-8025----1件: 93
1028MY008211A tablets----1件: 62
1029Myalept1件: Metreleptin1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
1030Mycodigest supplement----2件: 96, 97
1031Mycofenolate Mofetil (MMF)----1件: 226
1032Mycophenolat-Natrium----1件: 66
1033Mycophenolate1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300
1034Mycophenolate mofeti1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 95
1035Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300
1036Mycophenolate mofetil (CellCept)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 11, 13
1037Mycophenolate mofetil (MMF)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬7件: 13, 49, 51, 60, 65, 66, 222
1038Mycophenolate Mofetil (MMF) 3 g/Day2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 35
1039Mycophenolate Mofetil 2 g/Day2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 35
1040Mycophenolate mofetil 2000mg/d2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 53
1041Mycophenolate Mofetil 500mg2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬3件: 49, 51, 61
1042Mycophenolate mofetil [CellCept]2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 11
1043Mycophenolate mofetil orally 1000 mg twice a day (BID)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222
1044Mycophenolate mofetil plus lower dose of Prednisone3件: Mycophenolate mofetil,
Mycophenolic acid,
Prednisone		3件: D00473 ,
D00752 ,
D05096 		3件: IMPDH1,
IMPDH2,
NR3C1 💬		5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬1件: 66
1045Mycophenolate mofetil TEVA2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 53
1046Mycophenolate mofetil(MMF)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 224
1047Mycophenolate mofetil, low dose steroid2件: Mycophenolate mofetil,
Mycophenolic acid		2件: D00752 ,
D05096 		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222
1048Mycophenolate mofetil,methotrexate3件: Methotrexate,
Mycophenolate mofetil,
Mycophenolic acid		3件: D00142 ,
D00752 ,
D05096 		4件: DHFR,
DHFR2,
IMPDH1,
IMPDH2 💬		8件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, Nucleotide metabolism, One carbon pool by folate, Purine metabolism 💬3件: 42, 43, 45
1049Mycophenolate motetil1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49
1050Mycophenolate sodium1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬3件: 53, 66, 222
1051Mycophenolic acid1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬8件: 11, 43, 49, 51, 60, 66, 96, 222
1052Mycophenolic acid mofetil1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 60
1053Mycophenolic sodium----2件: 66, 222
1054Mycophenylate mofetil----2件: 19, 20
1055Mycophénolate mofétil----1件: 44
1056Myelin1件: Myelin basic protein---1件: 13
1057Myeloablative conditioning regimen----1件: 164
1058Myeloablative Conditioning-Closed with amendment L----1件: 65
1059Myeloablative Preparative Regimen----3件: 62, 65, 284
1060MYELOSTIM----1件: 65
1061MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML----2件: 19, 65
1062MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion----1件: 65
1063MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion----1件: 65
1064MYELOSTIM 34*1FL 263MCG+1SIR----1件: 2
1065Myfortic1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬5件: 49, 66, 162, 222, 228
1066Myfortic 180 mg1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162
1067Myfortic 180 mg Filmtabletten1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 162
1068Myfortic 180mg Tablets1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 66, 222
1069Myfortic 360mg Tablets1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 66, 222
1070Myfortic plus low-dose steroid1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 222
1071MYFORTIC*50CPR RIV 360MG1件: Mycophenolic acid1件: D05096 2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬1件: 49
1072MYK-224----1件: 58
1073MYK-461----1件: 58
1074MYO-0291件: Stamulumab1件: D05917 1件: MSTN 💬1件: Cytokine-cytokine receptor interaction 💬1件: 113
1075Myoblast autologous graft----1件: 113
1076Myoblast transplantation----1件: 113
1077Myoblastes autologues----1件: 113
1078MYOBLOC1件: Botulinum toxin type B1件: D02735 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13
1079MYODM----1件: 113
1080Myonal----1件: 2
1081MYONAL*30CPR RIV 100MG----1件: 2
1082Myozyme1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1083Myozyme 50 mg powder for concentrate for solution for infusion1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1084MYOZYME®1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1085Myozyme® (alglucosidase alfa)1件: Alglucosidase alfa1件: D03207 1件: GAA 💬4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬1件: 256
1086MYRRH1件: Myrrh1件: D08948 --1件: 97
1087Myrrhinil-Intest®----1件: 97
1088Mysildecard----1件: 210
1089MZ101----1件: 210
1090Mémantine----1件: 6
1091Méthotrexate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 271
1092Méthotrexate Bellon Comprimé1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 271
1093Méthylprednisolone----1件: 13
1094Méthylprednisolone Mylan----1件: 13